Loading...
•
Jun 30, 2020
Royalty Pharma Q2 2020 Earnings Report
Royalty Pharma announced the launch of senior notes offering.
Key Takeaways
Royalty Pharma announced its intention to offer senior unsecured notes in a private offering to repay existing debt and for general corporate purposes.
Royalty Pharma plans to offer senior unsecured notes in multiple tranches.
The notes will be offered in a private offering exempt from registration.
The net proceeds will be used to repay existing Term Loan A and Term Loan B facilities.
Remaining proceeds will be used for general corporate purposes.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...